Bacteroides-Associated Pylephlebitis in a Patient with Strongyloidiasis

Stone, Neil; Martin, Thomas C.; Biswas, J S; Barrett, Jessica; Hickish, T.; Dasgupta, D.; Newsholme, William

doi:10.4269/ajtmh.14-0294

Cited by 7 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The role of anticoagulants and thrombolytics in the treatment of pylephlebitis is still under debate. There was 22% mortality in patients who did not receive anticoagulation when compared with 6% mortality in patients who received anticoagulation in one study 13 . Kanellopoulou et al 14 suggest that early use of anticoagulation prevents serious sequelae and hastens recanalization.…”

Section: Discussionmentioning

confidence: 98%

“…There was 22% mortality in patients who did not receive anticoagulation when compared with 6% mortality in patients who received anticoagulation in one study. 13 Kanellopoulou et al 14 suggest that early use of anticoagulation prevents serious sequelae and hastens recanalization. A study by Plemmons et al 15 noted a 100% survival rate in patients who received anticoagulation with heparin.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Atypical Pylephlebitis

Vanaparthy

Greene

2021

Infect Dis Clin Pract

View full text Add to dashboard Cite

Pylephlebitis is also called suppurative thrombophlebitis of the portal venous mesenteric system. It is often seen as a complication of intra-abdominal infection, mainly diverticulitis and appendicitis. It is a rare disease with high mortality. Because of its nonspecific presentation, diagnosis is usually missed. So, it is important to consider pylephlebitis as one of the differential diagnoses if the patient presents with signs of abdominal sepsis. Pylephlebitis usually begins with thrombophlebitis of small veins draining an area of intra-abdominal infection and extends into larger veins that cause septic thrombophlebitis of the portal vein and further extending to mesenteric veins. Here, we present the case series of 6 patients older than 60 years who have underlying abdominal cancer at the Moffitt Cancer Center and Research Institute and review the literature.

show abstract

Section: Discussionmentioning

confidence: 98%